|
|
|
Volumn 27, Issue 39, 1998, Pages 2113-2119
|
|
Anticancer chemotherapy: Prevention of complications;Chimiotherapie anticancereuse: Prevention des complications
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIFOSTINE;
ANTHRACYCLINE ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTOKINE;
DRUG CARRIER;
ETOPOSIDE;
FLUOROURACIL;
GLUTATHIONE;
GROWTH FACTOR;
IFOSFAMIDE;
MESNA;
METHOTREXATE;
RAZOXANE;
TAXANE DERIVATIVE;
ANTIDOTE;
IRON CHELATING AGENT;
PROTECTIVE AGENT;
AGE;
ANEMIA;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CARDIOTOXICITY;
DRUG INDUCED DISEASE;
HEART PROTECTION;
HEMATOPOIETIC CELL;
HUMAN;
LEUKEMIA;
LYMPHOMA;
NAUSEA;
NEPHROTOXICITY;
NEUROTOXICITY;
NEUTROPENIA;
REVIEW;
THROMBOCYTOPENIA;
VOMITING;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
DRUG EFFECT;
HEART;
NEOPLASM;
ANTIDOTES;
ANTINEOPLASTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GLUTATHIONE;
HEART;
HUMANS;
IRON CHELATING AGENTS;
MESNA;
NEOPLASMS;
PROTECTIVE AGENTS;
RAZOXANE;
VOMITING;
|
|
EID: 0032512351
PISSN: 07554982
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (79)
|
